Tougeron David, Fauquembergue Emilie, Rouquette Alexandre, Le Pessot Florence, Sesboüé Richard, Laurent Michèle, Berthet Pascaline, Mauillon Jacques, Di Fiore Frédéric, Sabourin Jean-Christophe, Michel Pierre, Tosi Mario, Frébourg Thierry, Latouche Jean-Baptiste
Inserm, U614, Faculty of Medicine, Institute for Medical Research, Rouen, Northwest Cancéropôle, France.
Mod Pathol. 2009 Sep;22(9):1186-95. doi: 10.1038/modpathol.2009.80. Epub 2009 Jun 5.
Colorectal cancers with microsatellite instability are characterized by an important density of tumor-infiltrating lymphocytes and a good prognosis. Microsatellite instability results from the inactivation of the DNA mismatch repair system and induces secondary somatic frameshift mutations within target genes harboring repeat sequences in their coding frame. By disrupting the open reading frame, frameshift mutations can result in the appearance of potentially immunogenic neopeptides. To determine the frameshift mutations inducing a T-cell response during the development of a tumor with microsatellite instability, we studied in 61 colorectal cancer patients with microsatellite instability, using a fluorescent multiplex PCR comparative analysis, the relative frequency of frameshift mutations within 19 target genes and analyzed the correlation of these frameshift mutations with the density of CD3+ tumor-infiltrating lymphocytes. The four most frequently mutated genes were ACVR2 (92%), TAF1B (84%), ASTE1/HT001 (80%) and TGFBR2 (77%). The vast majority (95%) of the tumors exhibited at least three frameshift mutations, and the number of frameshift mutations was associated with tumor progression (TNM stage, wall invasion and tumor diameter). Tumor-infiltrating lymphocyte density was associated with the overall number of frameshift mutations and with the presence of frameshift mutations within two target genes, namely ASTE1/HT001 and PTEN. These results strongly argue for the clinical relevance of immunotherapy of colorectal cancers with microsatellite instability.
微卫星不稳定的结直肠癌的特征是肿瘤浸润淋巴细胞密度高且预后良好。微卫星不稳定是由DNA错配修复系统失活导致的,并在编码框中含有重复序列的靶基因内诱导继发性体细胞移码突变。通过破坏开放阅读框,移码突变可导致潜在免疫原性新肽的出现。为了确定在微卫星不稳定肿瘤发生过程中诱导T细胞反应的移码突变,我们对61例微卫星不稳定的结直肠癌患者进行了研究,采用荧光多重PCR比较分析方法,检测了19个靶基因内移码突变的相对频率,并分析了这些移码突变与CD3+肿瘤浸润淋巴细胞密度的相关性。四个最常发生突变的基因是ACVR2(92%)、TAF B(84%)、ASTE1/HT001(80%)和TGFBR2(77%)。绝大多数(95%)肿瘤至少有三个移码突变,移码突变的数量与肿瘤进展(TNM分期、肠壁浸润和肿瘤直径)相关。肿瘤浸润淋巴细胞密度与移码突变的总数以及两个靶基因ASTE1/HT001和PTEN内移码突变的存在相关。这些结果有力地证明了微卫星不稳定的结直肠癌免疫治疗的临床相关性。